JPRN-UMIN000015900
Completed
未知
Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg Tablets - Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg Tablets
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Attention deficit hyperactivity disorder (ADHD)
- Sponsor
- Janssen Pharmaceutical K.K
- Enrollment
- 500
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients of continuous treatment with CONCERTA Tablets from childhood to adult with ADHD is excluded from the study of the subject
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Special Drug Use-results Surveillance for long term administration of XEPLION (Paliperidone Palmitate 1 month formulation), 25mg/ 50mg/ 75mg/ 100mg/ 150mg syringeSchizophreniaJPRN-UMIN000018665Janssen Pharmaceutical K.K.1,050
Recruiting
Not Applicable
Special Drug Use Results Surveillance for the use of Odefsey in pregnant womeHIV/AIDSJPRN-UMIN000034028Janssen Pharmaceutical K.K.3
Completed
Not Applicable
Special drug use results surveillance for the use of SIMPONI in ulcerative colitisulcerative colitisJPRN-UMIN000027542Janssen Pharmaceutical K.K.300
Recruiting
Not Applicable
Special drug use-results surveillance <Patients with cold agglutinin disease>Cold agglutinin diseaseJPRN-UMIN000049607sanofi K.K.100
Recruiting
Not Applicable
Protocol Number; CBAF312A1401JPRN-jRCT2031200377Sugimoto Toshiya330